Prion diseases are some of the most intriguing infectious disorders affecting the brains of humans and animals. The prevalent hypothesis proposes that the infectious agent is a misfolded protein that propagates in the absence of nucleic acid by transmission of its altered folding to the normal host version of the protein. This article details the evidence for and against the prion hypothesis, including results of recent studies in yeast, in which a prion phenomenon has also been identified. The evidence in favor of the prion model is very strong, but final proof—consisting of the generation of infectious prions in vitro—is still missing.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Collinge, J. Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24, 519–550 (2001).
Prusiner, S.B. Prions. Proc. Natl. Acad. Sci. USA 95, 13363–13383 (1998).
Will, R.G. et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921–925 (1996).
Collinge, J. Variant Creutzfeldt-Jakob disease. Lancet 354, 317–323 (1999).
Cullie, J. & Chelle, P.L. Experimental transmission of trembling to the goat. C. R. Seances Acad. Sci. 208, 1058–1160 (1939).
Chandler, R.L. Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1, 1378–1379 (1961).
Gajdusek, D.C., Gibbs, C.J. & Alpers, M. Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 209, 794–796 (1966).
Gibbs, C.J. Jr et al. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 161, 388–389 (1968).
Masters, C.L., Gajdusek, D.C. & Gibbs, C.J., Jr. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Straussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 104, 559–588 (1981).
Cho, H.J. Is the scrapie agent a virus? Nature 262, 411–412 (1976).
Alper, T., Cramp, W.A., Haig, D.A. & Clarke, M.C. Does the agent of scrapie replicate without nucleic acid? Nature 214, 764–766 (1967).
Alper, T., Haig, D.A. & Clarke, M.C. The exceptionally small size of the scrapie agent. Biochem. Biophys. Res. Commun. 22, 278–284 (1966).
Kimberlin, R.H. Scrapie agent: prions or virinos? Nature 297, 107–108 (1982).
Griffith, J.S. Self-replication and scrapie. Nature 215, 1043–1044 (1967).
Prusiner, S.B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136–144 (1982).
Bolton, D.C., McKinley, M.P. & Prusiner, S.B. Identification of a protein that purifies with the scrapie prion. Science 218, 1309–1311 (1982).
Gabizon, R., McKinley, M.P., Groth, D. & Prusiner, S.B. Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc. Natl. Acad. Sci. USA 85, 6617–6621 (1988).
Enari, M., Flechsig, E. & Weissmann, C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. USA 98, 9295–9299 (2001).
Peretz, D. et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739–743 (2001).
Oesch, B. et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 40, 735–746 (1985).
Chesebro, B. et al. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315, 331–333 (1985).
Stahl, N. et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32, 1991–2002 (1993).
Pan, K.M. et al. Conversion of α-helices into β-sheets features in the formation of scrapie prion poteins. Proc. Natl. Acad. Sci. USA 90, 10962–10966 (1993).
Hsiao, K.K. et al. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250, 1587–1590 (1990).
Hsiao, K.K. et al. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc. Natl. Acad. Sci. USA 91, 9126–9130 (1994).
Barron, R.M. & Manson, J.C. A gene-targeted mouse model of P102L Gerstmann-Straussler-Scheinker syndrome. Clin. Lab. Med. 23, 161–173 (2003).
Bueler, H. et al. Mice devoid of PrP are resistant to Scrapie. Cell 73, 1339–1347 (1993).
Rubenstein, R., Carp, R.I. & Callahan, S.M. In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J. Gen. Virol. 65, 2191–2198 (1984).
Race, R.E., Fadness, L.H. & Chesebro, B. Characterization of scrapie infection in mouse neuroblastoma cells. J. Gen. Virol. 68, 1391–1399 (1987).
Kocisko, D.A. et al. Cell-free formation of protease-resistant prion protein. Nature 370, 471–474 (1994).
Saborio, G.P., Permanne, B. & Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810–813 (2001).
Chesebro, B. BSE and prions: uncertainties about the agent. Science 279, 42–43 (1998).
Safar, J. et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4, 1157–1165 (1998).
Caughey, B., Raymond, G.J. & Bessen, R.A. Strain-dependent differences in β-sheet conformations of abnormal prion protein. J. Biol. Chem. 273, 32230–32235 (1998).
Bessen, R.A. et al. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375, 698–700 (1995).
Lasmezas, C.I. et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275, 402–405 (1997).
Hill, A.F. et al. Species-barrier-independent prion replication in apparently resistant species. Proc. Natl. Acad. Sci. USA 97, 10248–10253 (2000).
Narang, H. A critical review of the nature of the spongiform encephalopathy agent: protein theory versus virus theory. Exp. Biol. Med. 227, 4–19 (2002).
Weiss, S. et al. RNA aptamers specifically interact with the prion protein PrP. J. Virol. 71, 8790–8797 (1997).
Derrington, E. et al. PrPC has nucleic acid chaperoning properties similar to the nucleocapsid protein of HIV-1. C. R. Acad. Sci. III 325, 17–23 (2002).
Deleault, N.R., Lucassen, R.W. & Supattapone, S. RNA molecules stimulate prion protein conversion. Nature 425, 717–720 (2003).
Soto, C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 49–60 (2003).
Kane, M.D. et al. Evidence for seeding of β-amyloid by intracerebral infusion of Alzheimer brain extracts in β-amyloid precursor protein-transgenic mice. J. Neurosci. 20, 3606–3611 (2000).
Lundmark, K. et al. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl. Acad. Sci. USA 99, 6979–6984 (2002).
Lehmann, S. & Harris, D.A. Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proc. Natl. Acad. Sci. USA 93, 5610–5614 (1996).
Chiesa, R., Piccardo, P., Ghetti, B. & Harris, D.A. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21, 1339–1351 (1998).
Jackson, G.S. et al. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283, 1935–1937 (1999).
Hill, A.F., Antoniou, M. & Collinge, J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol. 80, 11–14 (1999).
Barret, A. et al. Evaluation of quinacrine treatment for prion diseases. J. Virol. 77, 8462–8469 (2003).
Wickner, R.B. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264, 566–569 (1994).
Uptain, S.M. & Lindquist, S. Prions as protein-based genetic elements. Annu. Rev. Microbiol. 56, 703–741 (2002).
Sparrer, H.E., Santoso, A., Szoka, F.C., Jr & Weissman, J.S. Evidence for the prion hypothesis: induction of the yeast [PSI+] factor by in vitro-converted Sup35 protein. Science 289, 595–599 (2000).
Maddelein, M.L., Dos, R.S., Duvezin-Caubet, S., Coulary-Salin, B. & Saupe, S.J. Amyloid aggregates of the HET-s prion protein are infectious. Proc. Natl. Acad. Sci. USA 99, 7402–7407 (2002).
King, C.Y. & Diaz-Avalos, R. Protein-only transmission of three yeast prion strains. Nature 428, 319–323 (2004).
Tanaka, M., Chien, P., Naber, N., Cooke, R. & Weissman, J.S. Conformational variations in an infectious protein determine prion strain differences. Nature 428, 323–328 (2004).
We thanks K. Maundrell (Serono), K. Abid and P. Saa (University of Texas Medical Branch) for critical reading of the manuscript and for helpful discussions.
The authors declare no competing financial interests.
About this article
Cite this article
Soto, C., Castilla, J. The controversial protein-only hypothesis of prion propagation. Nat Med 10, S63–S67 (2004). https://doi.org/10.1038/nm1069
Molecular Psychiatry (2018)
Structural transitions in full-length human prion protein detected by xenon as probe and spin labeling of the N-terminal domain
Scientific Reports (2016)
JBIC Journal of Biological Inorganic Chemistry (2014)
Analytical and Bioanalytical Chemistry (2013)
Nature Structural & Molecular Biology (2012)